Sarah Lively

Sarah Lively

Senior Director, External Innovation DPDS

Janssen R&D US

Why I'm a JPAL

I'm excited to be able to share my experience with startup companies and to help guide them to success as I am able. I am also enthusiastic to look for ways that Janssen may be able to collaborate and partner with our JLABS residents.

Bio

Sarah Lively, Senior Director, External Innovation, Discovery, Product Development & Supply (DPDS), is located at the Johnson & Johnson Innovation Center in South San Francisco, California. In this role, she has overall strategic and operational responsibility for the scouting and evaluation of external opportunities for DPDS in Western North America, Australia and New Zealand across all synthetic drug modalities. She provides transactional support from a scientific and strategic perspective for DPDS-driven deals and assists the Therapeutic Area Innovation Leads with her scientific and technological expertise. Sarah also partners with the JLABS organization to identify and foster start-up companies that are aligned with DPDS strategy.

之前to joining Johnson & Johnson Innovation, Sarah was VP of Innovation and New Technology at ChemPartner, a global discovery CRO organization for which she set up and managed US lab operations and led initiatives to broker partnerships with academic institutes for early stage therapeutic discovery. She also introduced novel versions of B-cell cloning and DNA-encoded library (DEL) technologies to ChemPartner. Sarah has more than 20 years of experience in the biotech and pharmaceutical industries and has taken the lead in various small molecule discovery programs across a range of therapeutic areas, most notably at Tularik and Amgen.

Sarah is a skilled medicinal chemist and holds a Bachelors in Chemistry from Loughborough University and a Ph.D. in Synthetic Organic Chemistry from the University of Sheffield in the UK.